Muting mutase improves ovarian cancer drug sensitivity
Researchers at the Chinese Academy of Sciences (Shanghai, China) have revealed how new understanding of DNA repair pathways could increase the range of cancers treatable with Olaparib.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.